Powered by Smartsupp

High cholesterol and atherosclerosis: symptoms, results and lowering LDL

KINGRAY Academy · educational series on the heart, blood and blood vessels.
KINGRAY ACADEMY · HEART 08 · EDUCATIONAL ARTICLE

How can you lower cholesterol, and what do your LDL results mean?

Atherosclerosis is a long-term process in the walls of arteries that leads to the formation of arterial plaque. Cholesterol-containing lipoprotein particles, cells in the artery wall and inflammatory mechanisms all contribute.

What does high cholesterol mean, what are the symptoms of atherosclerosis and how can cholesterol be lowered? We explain how plaque forms, how it differs from a blood clot and what LDL-C, HDL-C, non-HDL cholesterol, apoB and Lp(a) mean. Blood test results are assessed alongside overall cardiovascular risk.

Author: Ing. František Kokoš · Updated:
First published:

For practical comparisons when choosing, visit our advice guides: Advice: heart and circulation → · Advice: memory and focus →

01 · Atherosclerosis: what does “blocked arteries” mean?

Illustration: plaque forms in the artery wall and can narrow the space through which blood flows.
Illustration: plaque forms in the artery wall and can narrow the space through which blood flows.

Atherosclerosis is a chronic process in artery walls in which atherosclerotic plaque gradually forms. It is more than simply “fat building up”. Cholesterol-containing lipoproteins, cells in the artery wall, immune and inflammatory mechanisms and other risk factors are involved.

Plaque can change the structure of the artery wall and restrict blood flow. A clinical problem can also arise when a plaque is disrupted and a blood clot subsequently forms.In simple terms: Plaque is a change in the artery wall. A clot forms from blood and can suddenly restrict flow at a disrupted plaque. They are not the same thing.

Cholesterol matters, but it is not the whole story. Atherosclerosis is a process in the artery wall influenced by several factors at once.

Scientific sources: [5], [6].

The expression “blocked arteries” is commonly used for narrowed or closed arteries. However, the presence of plaque alone does not mean that an artery is completely blocked.

What are the symptoms of atherosclerosis?

02 · How does arterial plaque form?

Illustration: atherosclerotic plaque develops gradually in the artery wall; this is not a microscopic photograph.
Illustration: atherosclerotic plaque develops gradually in the artery wall; this is not a microscopic photograph.

In simple terms, the process can be understood as a long-term interaction between the artery wall and atherogenic lipoproteins. Particles containing apoB can enter and become retained in the artery wall. Cellular and inflammatory mechanisms then become involved, and the plaque may gradually grow and change.

1. Artery wall The endothelium regulates many processes between the blood and the vessel wall.
2. Atherogenic particles Lipoproteins containing apoB are particularly important.
3. Inflammatory response Immune cells respond to retained lipoproteins.
4. Plaque Its composition and stability can change over time.

Macrophages, cells of the immune system, take up lipids and can become foam cells. Plaque may contain lipids, cell debris and fibrous tissue. Its development is not the same in every person.In simple terms: Some immune cells take up fatty substances and accumulate them. Together with other changes in the artery wall, they contribute to plaque formation.

Plaque and a clot are not the same thing.
Plaque is a change in the artery wall. A blood clot can form on its disrupted surface and suddenly restrict or stop blood flow. It is not simply a “piece of fat” breaking loose from a pipe.

Scientific sources: [5], [6].

03 · LDL and HDL: “bad” and “good” cholesterol

Cholesterol is a substance the body needs. As it does not dissolve in water, it is transported in the blood in particles called lipoproteins. It is therefore useful to distinguish cholesterol itself from the particles that carry it.

LDLHDL
Schematic illustration of lipoprotein particles: LDL carries cholesterol to tissues; HDL contributes to reverse cholesterol transport. Sizes and colours are illustrative, not to scale; this is not a micrograph.

LDL and HDL are carriers, not two types of cholesterol. LDL particles have a causal role in atherosclerosis, and higher LDL-C increases risk; a higher HDL-C value alone does not cancel out that risk. Lipid profile results are therefore assessed alongside other risk factors.In simple terms: Cholesterol is the cargo and lipoproteins are its carriers. Higher HDL alone does not offset the risk associated with high LDL.

LDL Elevated LDL-C is one of the main treatment targets in the prevention of atherosclerotic cardiovascular disease.
HDL A different group of lipoproteins. A high HDL-C value alone does not automatically mean low overall risk.

Scientific sources: [6], [7].

04 · LDL-C, non-HDL cholesterol and apoB

LDL-C expresses the amount of cholesterol carried by LDL particles. Non-HDL cholesterol includes cholesterol in all atherogenic lipoproteins. ApoB is a structural protein of atherogenic particles and can help estimate their number.

Why use several markers?
In some people, the amount of cholesterol in particles and the number of atherogenic particles can give different pictures. Doctors therefore interpret results in the context of overall risk.

LDL-C — The amount of cholesterol carried by LDL particles.

Non-HDL cholesterol — Cholesterol in all lipoproteins other than HDL; it includes atherogenic particles.

ApoB — A marker of the number of atherogenic lipoprotein particles.

HDL-C — The amount of cholesterol carried by HDL particles; it is not assessed in isolation.

Triglycerides — Another type of fat in the blood; the result adds to the lipid and metabolic profile.

Lp(a) — A largely genetically determined lipoprotein that can refine risk assessment.

Non-HDL cholesterol is calculated as total cholesterol minus HDL-C, with both values expressed in the same units. Measuring apoB provides additional information about particle number, which can differ from the amount of cholesterol they carry.In simple terms: LDL-C tells us about the amount of cholesterol in LDL particles. ApoB helps estimate the number of particles associated with risk. The same amount of cargo does not necessarily mean the same number of carriers.

A laboratory reference range is not automatically your personal treatment target. The LDL-C target depends on overall risk and any existing conditions.In simple terms: A value described as normal by a laboratory may not be an appropriate target for someone who has had a heart attack or is at higher risk.

Scientific sources: [1], [7].

05 · HDL and elevated triglycerides

Triglycerides are another type of fat in the blood, and elevated levels can be part of a metabolic risk profile. HDL-C is often called “good cholesterol”, but this simplification has limits. Cardiovascular risk is not assessed using a single number.

The whole profile matters: LDL-C, non-HDL-C, triglycerides, sometimes apoB and Lp(a), as well as blood pressure, blood glucose, smoking, age, family history and existing disease.In simple terms: One blood test result is only part of the picture. A doctor considers it alongside factors such as blood pressure, blood sugar, smoking and family history.

Scientific sources: [1], [7].

06 · Lipoprotein(a) – Lp(a)

Lp(a) is a lipoprotein particle whose level is largely genetically determined. Current European recommendations use it as a factor that can refine the assessment of cardiovascular risk.

ESC/EAS guidelines advise considering Lp(a) measurement at least once in every adult’s lifetime. [1]

An Lp(a) result is not interpreted in isolation. It is particularly relevant alongside the overall risk profile and family history.In simple terms: Lp(a) is largely influenced by heredity. Its result adds information about risk but does not establish a diagnosis on its own.

Scientific sources: [1].

07 · What increases the risk of atherosclerosis?

🚬 Smoking An important modifiable cardiovascular risk factor.
🩺 High blood pressure Persistently elevated blood pressure increases cardiovascular risk.
🍬 High blood glucose and diabetes Metabolic health is closely linked to blood vessel health.
🧪 Elevated atherogenic lipoproteins LDL-C and other apoB-containing particles are a key part of the atherosclerotic process.
🧬 Genetics and family history Some risk factors cannot be changed but can be taken into account in prevention.
🚶 Lack of exercise and an unhealthy diet These affect several metabolic risk factors at once.

Scientific sources: [2], [3], [6].

Familial hypercholesterolaemia: high cholesterol despite a healthy diet

08 · Which tests are used?

Depending on age, family history and overall risk, a doctor may assess the lipid profile, blood pressure, blood glucose or HbA1c, kidney function and other parameters. In some situations, apoB or Lp(a) testing is added.

Imaging tests are not used in the same way for everyone. In selected people, findings of subclinical atherosclerosis or coronary artery calcium can help refine risk assessment and treatment decisions.In simple terms: Subclinical atherosclerosis means changes that may not yet cause symptoms. Imaging can help refine the risk assessment in selected people.

A laboratory result is not a diagnosis on its own.
The meaning of a number depends on a person's overall cardiovascular risk.
What can a drop of blood not show?
A microscopic image of a fresh drop of blood does not determine LDL-C, apoB or Lp(a) levels and does not confirm plaque in an artery. Blood lipids are assessed through laboratory testing; imaging the arteries is a separate method.

Scientific sources: [1], [7].

09 · How to lower cholesterol: diet and exercise

Preventing atherosclerotic cardiovascular disease does not depend on a single food or supplement. A combination of long-term habits matters.

🚭 do not smoke and avoid tobacco smoke
🚶 take regular exercise appropriate to your health
🥗 eat a varied diet focusing on minimally processed foods
🩺 monitor and treat high blood pressure
🍬 manage blood glucose and diabetes
⚖️ maintain an appropriate body weight and sustainable long-term habits

WHO lists an unhealthy diet, physical inactivity, tobacco use and harmful alcohol use among the main modifiable cardiovascular risk factors; these can lead to raised blood pressure, glucose and blood lipids, and obesity.

The quality of dietary fats and sources of fibre, such as vegetables, pulses and wholegrain foods, also matter when choosing what to eat.

Scientific sources: [3], [4].

Diet for high cholesterol: which foods should you limit and what can replace them?

Blood lipids, fibre and microcirculation

Vascular care involves blood lipids, the condition of the endothelial lining, microcirculation and chronic inflammatory processes. With elevated triglycerides (TG), reducing added sugar, sugary drinks, excess refined carbohydrates and alcohol, exercising regularly and losing weight when overweight can help. Replacing some saturated fats with unsaturated fats and consuming enough soluble fibre can help lower LDL cholesterol. [13]

Viscous forms of fibre, such as oat beta-glucans or psyllium, help limit bile acid reabsorption and promote their excretion. Fewer bile acids return to the liver. The liver uses cholesterol to make new bile acids; increased uptake of LDL particles from the blood is one mechanism that helps lower LDL cholesterol. A clinical study of oat beta-glucans found increased bile acid excretion and synthesis. [17]Simply put: Some fibre helps carry bile acids out in the stool. The liver then uses cholesterol to replace them. This is one way fibre can help lower LDL.

Exercise and weight management can also favourably influence HDL. Results are checked with follow-up blood lipid tests. Good microcirculation supplies tissues with oxygen and nutrients; limiting chronic inflammation that damages blood vessels also matters.

10 · Cholesterol medicines: statins and other options

The need for treatment is not determined by a single cholesterol value. A doctor considers overall cardiovascular risk, existing atherosclerotic disease, diabetes, kidney function, age, other risk factors and the lipid levels achieved.

Medicines used to lower LDL-C include statins and, depending on individual circumstances, other treatment options. Current ESC/EAS recommendations emphasise treatment based on overall risk and LDL-C targets.

Do not stop prescribed treatment on your own.
If you experience side effects or have questions about medicines, discuss them with your doctor. There are different ways to adjust treatment to the individual situation.

Scientific sources: [1], [7].

Statins reduce cholesterol production in the liver. Depending on risk and treatment response, other options include ezetimibe, which reduces cholesterol absorption in the intestine, PCSK9 inhibitors or bempedoic acid. The choice of medicine and combination is a medical decision; not everyone needs the same treatment.In simple terms: Medicines work in different ways. Some reduce cholesterol production, others reduce its absorption or help lower LDL through another mechanism. A doctor determines the appropriate combination.

Can plaque be removed from arteries naturally?

What does light research show about perfusion and blood lipids?

Photobiomodulation is being studied in this context. A small randomised study observed improved local perfusion with a specific light application. [14] A retrospective pilot study of intravenous laser irradiation of blood in 60 patients observed lower TG, but had no control group, so the change cannot reliably be attributed to the application alone. [15] In a study of 56 women receiving light through the skin over the radial artery, HDL increased with one of the tested protocols. [16] Findings concerning blood lipids remain preliminary and depend on the specific application method.Simply put: Improvement in one marker in a small study does not prove that light therapy prevents heart attacks or replaces medicines. Different application methods are not automatically interchangeable.

11 · Symptoms of a heart attack and stroke

Atherosclerosis can remain symptom-free for a long time. However, sudden chest pain or pressure, severe shortness of breath, sudden weakness on one side of the body, speech problems, facial drooping, sudden vision problems or other acute neurological symptoms require immediate medical help.

Do not wait if you suspect a heart attack or stroke.
In the EU, call 112.

Scientific sources: [3], [5].

12 · Frequently asked questions

Is cholesterol bad?

No. The body needs cholesterol. In atherosclerosis, what matters is which lipoprotein particles carry it, their concentration and overall cardiovascular risk.

Scientific sources: [6] [7]

Is LDL the same as cholesterol?

Not exactly. LDL is a lipoprotein particle; LDL-C expresses the amount of cholesterol carried by LDL particles.

Scientific sources: [7]

Is having high HDL enough?

No. HDL-C is only one part of the lipid profile and does not by itself erase the risk associated with high LDL-C, smoking, hypertension, diabetes or other factors.

Scientific sources: [1] [7]

What is apoB?

ApoB is a protein found on atherogenic lipoprotein particles. Measuring it can, in some situations, help refine the estimate of the number of atherogenic particles.

Scientific sources: [7]

What is Lp(a)?

Lipoprotein(a) is a largely genetically determined risk factor. An elevated level can change the overall estimate of cardiovascular risk.

Scientific sources: [1]

Can I stop taking cholesterol medicines if I change my diet?

Do not change or stop prescribed treatment without consulting your doctor. The need for treatment depends on overall risk and health status.

Scientific sources: [1] [7]

Is arterial plaque the same as a blood clot?

No. Plaque forms in the artery wall. A clot results from blood coagulation and can form on the disrupted surface of a plaque. It can then suddenly restrict blood flow.

Scientific sources: [5]

Can atherosclerosis occur without symptoms?

Yes. It can develop for a long time without obvious symptoms. The absence of symptoms alone therefore does not rule out risk; assessment also draws on examinations and personal or family history.

Scientific sources: [8]

What are the symptoms of high cholesterol?

High cholesterol usually causes no symptoms. It is reliably detected with a blood test of the lipid profile; feeling well or having no pain does not rule out elevated LDL cholesterol.

Scientific sources: [9]

How can cholesterol be lowered without medicines?

Changing the types of fat in the diet, increasing soluble fibre, exercising regularly and losing an appropriate amount of weight if overweight may help. Whether these measures are enough depends on the results and overall risk. Medicines are often also needed in people at high risk or with an inherited disorder.

Scientific sources: [10]

What cholesterol levels are normal?

The LDL-C target is not the same for everyone. It depends mainly on overall cardiovascular risk and existing disease. A laboratory reference range may therefore not be your treatment target.

Scientific sources: [1] [7]

Can diet or supplements remove arterial plaque?

Diet is part of prevention and treatment, but it does not guarantee plaque removal. Supplements should not be regarded as artery cleaners either. The aim is to reduce the risk of complications and stabilise the disease; effective treatment may also lead to partial plaque regression in some people.

Scientific sources: [11]

Key takeaways

Atherosclerosis develops in the artery wall, and its risk cannot be assessed from a single number. Blood lipids, blood pressure, blood sugar, smoking, heredity and existing conditions all matter. Long-term habits and treatment when needed help reduce the risk of complications. Discuss test results with a doctor; feeling well or having high HDL alone does not rule out a problem.

KINGRAY girl – illustrated Advice mascot
Your KINGRAY Advice guide · illustration.

Looking for guidance on nutrition for your heart or brain?

Continue from our articles on blood and blood vessels to two practical advice guides. Choose a topic to compare supplement ingredients, daily amounts and precautions.

Heart, blood vessels and circulation

Need help comparing supplements in the heart and circulation category? Our guide compares ingredients, their forms and amounts per daily serving, with precautions about taking them alongside medicines.

Open the heart and circulation guide →

Brain, memory and cognitive function

Interested in memory, focus and mental performance? Our guide helps you compare supplement ingredients and distinguish authorised health claims from general promises.

Open the memory and focus guide →

The Academy explains the science; our advice guides help with practical choices. Supplements do not replace a varied diet, medical assessment or prescribed treatment.

Scientific sources

Scientific sources
  1. [1] ESC/EAS: 2025 Focused Update of the 2019 Guidelines for the management of dyslipidaemias. DOI: 10.1093/eurheartj/ehaf190. Open source ↗
  2. [2] ESC: 2024 Guidelines for the management of elevated blood pressure and hypertension. Open source ↗
  3. [3] WHO: Cardiovascular diseases (CVDs). 2025. Open source ↗
  4. [4] WHO: Healthy diet. 2026. Open source ↗
  5. [5] NHLBI/NIH: Atherosclerosis. Open source ↗
  6. [6] EAS Consensus Panel: Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights. 2020. DOI: 10.1093/eurheartj/ehz962. Open source ↗
  7. [7] ESC/EAS: 2019 Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Open source ↗
  8. [8] NHLBI/NIH: Atherosclerosis — Symptoms. Open source ↗
  9. [9] NHLBI/NIH: Blood Cholesterol — Symptoms. Open source ↗
  10. [10] NHLBI/NIH: Blood Cholesterol — Treatment. Open source ↗
  11. [11] NHLBI/NIH: Atherosclerosis — Treatment. Open source ↗
  12. [12] NHLBI/NIH: Blood Cholesterol — Causes and Risk Factors. Open source ↗
  13. [13] ACC: 2021 Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia. DOI: 10.1016/j.jacc.2021.06.011. Open source ↗
  14. [14] Gavish L. et al. Microcirculatory Response to Photobiomodulation—Why Some Respond and Others Do Not: A Randomized Controlled Study. 2020. DOI: 10.1002/lsm.23225. Open source ↗
  15. [15] Huang C.-Y. et al. Effects of Intravenous Laser Irradiation of Blood on Metabolic Markers in Patients With Hyperlipidemia: A Retrospective Pilot Study. 2026. DOI: 10.21873/invivo.14213. Open source ↗
  16. [16] Lizarelli R. F. Z. et al. Protocol-Dependent Effects of Transcutaneous Blood Systemic Photobiomodulation on Inflammatory, Metabolic, and Hemostatic Markers. 2026. DOI: 10.1002/jbio.202500525. Open source ↗
  17. [17] Ellegård L., Andersson H. Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. 2007. DOI: 10.1038/sj.ejcn.1602607. Open source ↗

Author's educational background material: Kokoš F. et al., Zdravé cievy, Kingray, 2025. Clinical information in the web version is based on the professional sources listed above.

Links and citations checked on 7 November 2026.

Educational information: This article does not replace an individual medical examination, diagnosis or treatment. Discuss new symptoms and unusual results with your doctor. Do not change or stop prescribed treatment based on this article.

KINGRAY Academy · educational series on the heart, blood and blood vessels.

Know your body.
Start with your heart.

Ing. František Kokoš
Author: Ing. František Kokoš
Ing. František Kokoš – Author of KINGRAY Academy and Advice Corner
Technician, nutrition adviser (graduate of the 150-hour Welko retraining programme, 2025) and creator of the KINGRAY nutraceuticals concept. Years of developing the BIOquant medical device and working with blood rheology and tissue oxygenation led him to realise that bodily health requires the full picture – linking microcirculation, cellular energy and proper nutrition. In his articles, he looks for the balance where the body understands and cooperates with us.
He is the author of the book Liečba svetlom (Light Therapy, ISBN 978-80-970512-0-4), co-author of the publication BIOquant – polovodičová laserová terapia (BIOquant – Semiconductor Laser Therapy, ISBN 978-80-970512-2-8), and originator of patents in light technologies (US9731145B2, SK5457Y1).
%s ...
%s
%image %title %code %s
%s